A Study of Immunotherapy Combined With Neoadjuvant Therapy Versus Neoadjuvant Therapy for Breast Cancer
Status:
Not yet recruiting
Trial end date:
2023-07-01
Target enrollment:
Participant gender:
Summary
This is a randomized, open label Phase II neoadjuvant study comparing the efficacy and safety
of the combination of traditional herbal medicine for cancer immunotherapy and neoadjuvant
therapy versus neoadjuvant therapy in patients with breast cancer.